Pharma News

Generic Doxil approval may help alleviate drug shortages

Home/Pharma News | Posted 08/02/2013

FDA announced on 4 February 2013 that the agency had approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection).

Brand-name drugmaker can be sued for harm caused by generic drug

Home/Pharma News | Posted 18/01/2013

On 4 January 2013 the Alabama Supreme Court ruled that Pfizer can be sued for failing to warn about a drug’s risks by a patient who claimed he was injured by a generic version of its gastric reflux medicine Reglan (metoclopramide).

Teva makes South Korean joint venture agreement

Home/Pharma News | Posted 11/01/2013

Teva Pharmaceutical Industries (Teva) announced on 16 December 2012 that it had made an agreement with Handok Pharmaceuticals (Handok) to establish a business venture in South Korea.

Teva cost-cutting and re-organization

Home/Pharma News | Posted 14/12/2012

Teva Pharmaceutical Industries’ (Teva’s) new Chief Executive vowed to reshape the drugmaker and reduce annual costs by up to US$2 billion over the next five years, making it into ‘the most indispensable medicines company in the world’.

Eli Lilly and Strides Arcolab in generics deal

Home/Pharma News | Posted 07/12/2012

Pharma giant Eli Lilly and India-based generics manufacturer Strides Arcolab announced on 5 December 2012 a collaboration to market the latter’s generic cancer drugs in emerging markets.

Sanofi to acquire Colombian generics maker

Home/Pharma News | Posted 12/10/2012

Healthcare major Sanofi announced on 2 October 2012 that it has signed an agreement to acquire Colombian generics manufacturer Laboratorios Genfar (Genfar), making Sanofi a market leader in Colombia and expand its portfolio of affordable pharmaceuticals in Latin America.

GPhA drug shortages plan gets FTC approval

Home/Pharma News | Posted 12/10/2012

On 8 August 2012 the US Federal Trade Commission (FTC) issued a positive advisory opinion to the Generic Pharmaceutical Association (GPhA) approving its Accelerated Recovery Initiative (ARI), which hopes to address drug shortage issues, after the FTC found the ARI will not be anticompetitive as sensitive information will be protected.

Fresenius cashes in on drug shortages

Home/Pharma News | Posted 21/09/2012

German healthcare conglomerate Fresenius has posted substantial growth across all regions and product areas during the first half of 2012 for its US business Fresenius Kabi. The growth has been largely attributed to rivals’ problems with supplying generics on the drug shortages list in the US.

Generics market set to increase in Japan

Home/Pharma News | Posted 14/09/2012

Japan has not been an easy place for drugmakers to do business. However, with government initiatives being introduced to increase generics use and taking into account the fact that Japan is currently the world’s second largest pharmaceutical market, it is perhaps not surprising that a new partnership is optimistic about the opportunities.